VALIANT: landmark study shows valsartan equal to captopril in MI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1418, 2003-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic captopril has cost advantage over valsartan after MI

By  

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

VALIANT (VALsartan In Acute myocardial iNfarcTion) trial

By Maggioni Aldo Pietro   Fabbri Gianna  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 507-512

Informa Healthcare

Access to resources Recommend Favorite

The angiotensin receptor blocker valsartan is as effective in reducing the risk of atherosclerotic events as captopril

By  

Inpharma, Vol. 1, Iss. 1531, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Addition of candesartan cilexetil to captopril beneficial post-MI

By  

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Adding captopril to canrenoic acid beneficial after MI

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite